CAPITOL COUNSEL LLC for MERCK & COMPANY, INC.
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Legislative issues related to tax reform.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHANNON FINLEY | — |
| JAMES O MCCRERY | — |
| DAVID OLANDER | — |
Copyright/Patent/Trademark CPT
Legislative issues related to Pharmaceutical patent issues; Legislative issues related to the FDA Regulation of Biosimilars.
| Lobbyist | Covered position, as disclosed |
|---|---|
| AARON COHEN | — |
| SHANNON FINLEY | — |
| CHARLES TOWNER FRENCH | — |
| DREW GOESL | — |
| MARTIN B. GOLD | — |
| LUKE HATZIS | — |
| DENISE HENRY MORRISEY | — |
| JAMES O MCCRERY | — |
| DAVID OLANDER | — |
| JOHN D RAFFAELLI | — |
Health Issues HCR
Diabetes Prevention & Treatment, including related provisions of HR 309, The National Clinical Care Commission Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| AARON COHEN | — |
| SHANNON FINLEY | — |
| SARA FRANKO | — |
| CHARLES TOWNER FRENCH | — |
| DREW GOESL | — |
| MARTIN B. GOLD | — |
| LUKE HATZIS | — |
| DENISE HENRY MORRISEY | — |
| ANN JABLON | — |
| JOHN D RAFFAELLI | — |
Medicare/Medicaid MMM
Medicare Coverage and Reimbursement issues, including the CMS Part B Drug Demonstration Proposed Rule; Medicare access to DXA services, including HR 2461, and legislative issues related to the CMS 2017 Hospital Outpatient Prospective Payment proposed rule; Medicare reimbursement for antimicrobial drugs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| AARON COHEN | — |
| SHANNON FINLEY | — |
| SARA FRANKO | — |
| CHARLES TOWNER FRENCH | — |
| DREW GOESL | — |
| MARTIN B. GOLD | — |
| LUKE HATZIS | — |
| DENISE HENRY MORRISEY | — |
| ANN JABLON | — |
| JOHN D RAFFAELLI | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.